APA (7th ed.) Citation

S, S., E, R., L, S., M, S., S, B., V, K., . . . AA, W. (2026). ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemia. Cell reports, 45(3), 117010. https://doi.org/10.1016/j.celrep.2026.117010

Chicago Style (17th ed.) Citation

S, Schäfer, et al. "ACSL4-associated Lipid Metabolism Is a Distinct Therapeutic Vulnerability in KMT2A-rearranged Acute Myeloid Leukemia." Cell Reports 45, no. 3 (2026): 117010. https://doi.org/10.1016/j.celrep.2026.117010.

MLA (9th ed.) Citation

S, Schäfer, et al. "ACSL4-associated Lipid Metabolism Is a Distinct Therapeutic Vulnerability in KMT2A-rearranged Acute Myeloid Leukemia." Cell Reports, vol. 45, no. 3, 2026, p. 117010, https://doi.org/10.1016/j.celrep.2026.117010.